Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.

Background: Hepatocellular carcinoma (HCC) is one of the main reasons for malignancy-related death. Portal vein tumor thrombosis (PVTT) is the most common form of macrovascular invasion related to HCC occurring in 10%-60% of patients. HCC with PVTT is usually characterized by worsening liver function, vulnerability to blood metastasis, higher incidence of complications associated with portal hypertension, and intolerance to treatment when compared with that without PVTT.

Synthesis and Characterization of High-Efficiency Red Phosphorescent Iridium(III) Complexes with 1-(4-(Trifluoromethyl)phenyl)isoquinoline Ligand.

Two new tfmpiq-based bis-cyclometalated iridium(III) complexes, [(tfmpiq)2Ir(imdzppo)] (2a) and [(tfmpiq)2Ir(idzpo)] (2b) (where tfmpiq = 1-(4-(trifluoromethyl)phenyl)isoquinoline, imdzppo = 2-(imidazo[1,2-a]pyridin-2-yl)phenol, idzpo = 2-(2H-indazol-2-yl)phenol), have been synthesized and fully characterized. The single crystal structure of 2b has been determined. The relationship between the structures and photophysical properties of both complexes are considered, and the DFT calculations have been used to further support the deduction.